ACS GCI Pharmaceutical Roundtable

In 2005, the ACS Green Chemistry Institute® and global pharmaceutical corporations developed the ACS GCI Pharmaceutical Roundtable to encourage innovation while catalyzing the integration of green chemistry and green engineering in the pharmaceutical industry. The activities of the Roundtable reflect its member's shared belief that the pursuit of green chemistry and engineering is imperative for business and environmental sustainability.


ACS GCIPR's mission is to catalyze the implementation of green chemistry and green engineering in the global pharmaceutical industry.

Strategic Priorities

  • Inform and Influence the Research Agenda
  • Tools for Innovation
  • Education Resource
  • Global Collaboration
More details on the Strategic Priorities

Member companies who are part of the ACS GCI Pharmaceutical Roundtable come together to catalyze innovative approaches to improving process efficiency and product quality through green chemistry and engineering. By working together, the Roundtable provides leadership and influence throughout the industry and supply chain. For example, the Pharmaceutical Roundtable has awarded over $1.3 million dollars in funding to further key research priorities for greener chemistries. In addition, the Roundtable continues to develop a valuable set of tools including a solvent selection guide, Process Mass Intensity/LCA calculator, and a powerful reagent guide. 

The ACS GCI Pharmaceutical Roundtable invites all corporations meeting the definition of membership to consider joining. Companies are encouraged to join if they are committed to the integration of green chemistry and green engineering into the business of drug discovery and production.

Find out more about Membership

Every year the ACS GCI Pharmaceutical Roundtable awards targeted grants to fund key research priorities. These grants spur impactful and highly relevant green chemistry research in alignment with the critical needs of the industry.



  • Research Grant for Greener Biologics Purification Methods ($150,000)
    Application closed
  • Research Grant for Greener Continuous Chemistry & Engineering Technology
    A. John Blacker, Ph.D., University of Leeds, $50,000 “Process Development of Continuous Flow Oxidative Biotransformations.”
    Graham Dobereiner, Ph.D., Temple University, $50,000   “Tandem catalytic process in flow: synthesis of amides via mild photochemical carbonylation using CO2 as a carbonyl source.”
    Amanda C. Evans, Ph.D., California State University, $50,000 “Enz-Flow/Continuous Bioprocessing: Towards a green continuous flow synthesis of levomilnacipran.” 
For a complete list of funded research, see Grants

The ACS GCI Pharmaceutical Roundtable is dedicated to developing high quality green chemistry tools for Roundtable members as well as the public.

Publicly Accessible Tools

Member Only Tools

  • Process Mass Intensity - Life Cycle Analysis (PMI-LCA) Tool
  • Reagent Guide

For more information, see the Green Chemistry Tools page

The ACS GCI Pharmaceutical Roundtable is a frequent and influential publisher. For example, "Key green chemistry research areas—a perspective from pharmaceutical manufacturers" published in Green Chemistry in 2007 has received over 283 citations. The Roundtable's most recent papers and presentations are:

  • Sustainable Chromatography (an oxymoron?), Emily A. Peterson, Barry Dillon, Izzat T. Raheem, Paul Richardson, Daniel Richter, Rachel Schmidt, and Helen F. Sneedon, Green Chemistry, July 14, 2014 (web), DOI: 10.1039/C4GC00615A
  • Green Chemistry Articles of Interest to the Pharmaceutical Industry, Rakeshwar Bandichhor, Apurba Bhattacharya, Louis Diorazio, Peter Dunn, Kenneth Fraunhoffer, Fabrice Gallou, John Hayler, Matthew Hickey, Bill Hinkley, David Hughes, Luke Humphreys, Bernard Kaptein, Suju Mathew, Lynnette Oh, Paul Richardson, Timothy White, Stijn Wuyts, Org. Process Res. Dev., 2014, 18 (7), pp 863-874. DOI: 10.1021/op500167y

For a complete list, see Publications.


To participate in the ACS GCI Pharmaceutical Roundtable, or for more information, please contact or call (202) 872-6102.